Navigation Links
Joint Venture Formed to Help Health Marketers Navigate Social Media Environment
Date:10/28/2009

NEW YORK, Oct. 28 /PRNewswire/ -- Extrovertic and Virilion announced today a joint venture, EV Healthcare, to help healthcare companies engage consumers in an increasingly social communications environment.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091028/PH00703LOGO )

"Innovating to meet the perpetually evolving needs of digital, social and mobile consumers is hard enough," says Dorothy Wetzel, co-founder and executive marketer at Extrovertic. "Doing it in the politically and emotionally charged healthcare arena is the ultimate challenge. But with Virilion's more than a decade of experience dealing with cause-related issues and crisis management, this venture greatly enhances our ability to create new 'pharma-safe' solutions that build brands."

"Virilion has long specialized in digital and social media for categories in the public eye," said Dan Solomon, CEO of Virilion. "We believe this competence, combined with Extrovertic's deep healthcare knowledge and creative acumen, will help pharma clients more effectively engage consumers in today's changing communications environment."

"DTC advertising is under assault. Clients today need new non-traditional creative solutions to help them tell more cohesive and engaging stories across all channels," added Mark Drossman, Extrovertic's co-founder and executive creative director, "and in the process, create more engaged brand advocates."

Extrovertic was founded by industry veterans Dorothy Wetzel -- formerly of Saatchi Healthcare and Pfizer Consumer Marketing -- and Mark Drossman -- formerly of Ogilvy and Euro RSCG -- in January. The agency's client roster includes a number of biotech companies.

Virilion has offices in Austin, Boston, New York and Washington, DC. Since 1997, the firm has worked for clients in categories ranging from food, agriculture and energy to media and entertainment. In the healthcare sector, Virilion has worked for Abbott, the Pharmaceutical Manufacturers of America, and Easter Seals.

EV Healthcare will be led out of the firms' New York offices.

    CONTACT: Mimi Carter, Publicist
    VIRILION
    mcarter@virilion.com
    202.654.0800

SOURCE EV Healthcare


'/>"/>
SOURCE EV Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients
2. Joint Commission Urges Patients to Speak Up About Pain
3. Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
4. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
5. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
6. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
7. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
8. Orthopaedic Surgeon Shortage Predicted Due to Soaring Joint Replacement Procedures
9. When to Have That Joint Replacement?
10. Beating Blood Clots after Joint Replacement
11. Octogenarians: Not Too Old for Joint Replacement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... Sept. 25, 2017   Montrium , an ... solutions, today—from the IQPC Trial Master Files & ... NL)—announced that EastHORN Clinical Services has selected ... and TMF management. EastHORN, a leading European contract ... to increase transparency to enable greater collaboration with ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform ... leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD ... dose required and providing a CBD form that can be easily incorporated into liquid ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
Breaking Medicine News(10 mins):